Patents by Inventor Andrey Shaw

Andrey Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8900845
    Abstract: Mutant KSR proteins are disclosed. The mutants include single amino acid substitutions, leading to either a loss of kinase activity or a loss of scaffolding activity. Also disclosed are methods of screening compounds for inhibitors of KSR kinase activity or KSR scaffolding activity. In some embodiments, the screening methods include protein complementation assays in which nucleic acids encoding fusion constructs comprising enzyme portions and kinase dimerization domains are expressed in cells. Inhibitors of dimerization can be indicated by loss of enzyme activity.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: December 2, 2014
    Assignee: Washington University
    Inventors: Andrey Shaw, Jiancheng Hu, Haiyang Yu
  • Publication number: 20120202233
    Abstract: Mutant KSR proteins are disclosed. The mutants include single amino acid substitutions, leading to either a loss of kinase activity or a loss of scaffolding activity. Also disclosed are methods of screening compounds for inhibitors of KSR kinase activity or KSR scaffolding activity. In some embodiments, the screening methods include protein complementation assays in which nucleic acids encoding fusion constructs comprising enzyme portions and kinase dimerization domains are expressed in cells. Inhibitors of dimerization can be indicated by loss of enzyme activity.
    Type: Application
    Filed: February 8, 2012
    Publication date: August 9, 2012
    Applicant: WASHINGTON UNIVERSITY
    Inventors: Andrey Shaw, Jiancheng Hu, Haiyang Yu
  • Publication number: 20060003356
    Abstract: Polymorphisms associated with the CD2AP protein are disclosed. Compositions and methods for the diagnosis and treatment of kidney disease are also disclosed.
    Type: Application
    Filed: May 11, 2005
    Publication date: January 5, 2006
    Applicant: Washington University
    Inventors: Andrey Shaw, Jeffrey Miner
  • Patent number: 5786454
    Abstract: Modified SH2 domains of intracellular proteins and methods of use, wherein the SH2 domains are modified to include an altered binding site for a signal transduction protein. The binding site is altered to either change the specificity of the SH2 domain for a signal transduction protein that is not the natural ligand or to include a reactive group, such as a reactive amino acid, that reacts with a phosphorylated amino acid of the signal transduction protein. The modified SH2 domains are useful as research tools or in methods for inactivating or inhibiting signal transduction proteins, especially those that contribute to disease or disorders such as cancer or for targeting specific SH2 domains for diagnostics.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: July 28, 1998
    Assignee: Washington University School of Medicine
    Inventors: Gabriel Waksman, Andrey Shaw